Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | ALPL | P05186 | 2/20 | 0.52 |
| ▸ | ALPI | P09923 | 1/20 | 0.52 |
| ▸ | ALPG | P10696 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21045164 | 1.00 | KMT2A (0.52) | KMT2AALPLALPIALPGPOLB | |
| SCHEMBL21045290 | 0.76 | MEN1 (0.62) | KMT2AALPLALPIALPG | |
| SCHEMBL29411536 | 0.76 | MEN1 (0.62) | KMT2AALPLALPIALPG | |
| SCHEMBL21045101 | 0.74 | ALDH1A1 (0.51) | KMT2A | |
| SCHEMBL29411527 | 0.74 | ALDH1A1 (0.51) | KMT2A | |
| SCHEMBL12633839 | 0.73 | KMT2A (0.72) | KMT2AALPLALPIALPGPOLB | |
| SCHEMBL21045103 | 0.72 | PKM (0.66) | KMT2APOLB | |
| SCHEMBL29411450 | 0.72 | PKM (0.66) | KMT2APOLB | |
| SCHEMBL21045147 | 0.69 | GRIA4 (0.48) | KMT2A | |
| SCHEMBL29411437 | 0.69 | GRIA4 (0.48) | KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250188035-A1 | TUBULIN INHIBITORS | LIN BIOSCIENCE LLC (US) | 2025-06-12 | — | — | US | disclosed |
| US-12247010-B2 | Tubulin inhibitors | LIN BIOSCIENCE INC. (TW) | 2025-03-11 | — | — | US | disclosed |
| US-20220089539-A1 | TUBULIN INHIBITORS | LIN BIOSCIENCE INC. (TW) | 2022-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220089539-A1 | TUBULIN INHIBITORS | TUBB3, TUBB1, TUBB | KMT2A 2339/4885ALPL 3620/4885ALPI 3765/4885 |
| US-12247010-B2 | Tubulin inhibitors | TUBB3, TUBB1, TUBB | KMT2A 2339/4885ALPL 3620/4885ALPI 3765/4885 |
| US-20250188035-A1 | TUBULIN INHIBITORS | TUBB3, TUBB1, TUBB | KMT2A 2339/4885ALPL 3620/4885ALPI 3765/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.